glucagon has been researched along with ptr 3173 in 1 studies
Studies (glucagon) | Trials (glucagon) | Recent Studies (post-2010) (glucagon) | Studies (ptr 3173) | Trials (ptr 3173) | Recent Studies (post-2010) (ptr 3173) |
---|---|---|---|---|---|
26,039 | 1,498 | 3,054 | 13 | 0 | 6 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afargan, M; Bracha, M; Gelerman, G; Gilon, C; Hoffman, A; Janson, ET; Karpov, O; Liapakis, G; Oberg, K; Rosenfeld, R; Shohat, D; Stephensky, D; Wolf, A; Ziv, O | 1 |
1 other study(ies) available for glucagon and ptr 3173
Article | Year |
---|---|
Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulin.
Topics: Animals; Binding, Competitive; Carcinoid Tumor; Cloning, Molecular; Cyclic AMP; Glucagon; Human Growth Hormone; Humans; Insulin; Insulin Secretion; Kinetics; Male; Octreotide; Pancreatic Neoplasms; Peptide Library; Radioligand Assay; Rats; Rats, Wistar; Receptors, Somatostatin; Recombinant Proteins; Somatostatin; Tumor Cells, Cultured | 2001 |